Search Results
Found 1 results
510(k) Data Aggregation
(175 days)
OCN
The KRONUS Insulin Autoantibody RIA Assay Kit is for the semi-quantitative determination of antibodies to insulin in human serum. The KRONUS Insulin Autoantibody RIA Assay is useful as an aid in the diagnosis of Type I diabetes mellitus (autoimmune mediated diabetes) in patients who have not received insulin therapy.
Not Found
This document is a 510(k) premarket notification letter from the FDA to KRONUS Market Development Associates, Inc. for their Insulin Autoantibody RIA Kit. It confirms that the device is substantially equivalent to legally marketed predicate devices. However, this document does not contain the acceptance criteria or a study that proves the device meets specific performance criteria.
The letter only states that the device is "substantially equivalent" to predicate devices, which is the basis for its clearance for market. It refers to "indications for use" but does not provide performance metrics or study details.
Therefore, I cannot extract the requested information from the provided text.
Ask a specific question about this device
Page 1 of 1